Versantis is a startup based in Switzerland, most recent round Acquired, 3 tracked investors.
Versantis is a company founded in 2014 headquartered in Switzerland. Versantis has been acquired. Brouky records 3 investors associated with the company.
Versantis is a clinical-stage biotech company developing novel drug therapies to treat liver, pediatric, and rare diseases using a proprietary detoxification platform. Its lead candidate VS-01 targets acute-on-chronic liver failure, and the company was acquired by Genfit in 2022.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.